AR032628A1 - Compuesto polimorfo de 1-{6-etoxi-5-[3-etil-6,7-dihidro-2-(2-metoxietil)-7-oxo-2h-pirazolo[4,3-d]pirimidin-5-il]-3-piridilsulfonil}-4-etilpiperazina - Google Patents

Compuesto polimorfo de 1-{6-etoxi-5-[3-etil-6,7-dihidro-2-(2-metoxietil)-7-oxo-2h-pirazolo[4,3-d]pirimidin-5-il]-3-piridilsulfonil}-4-etilpiperazina

Info

Publication number
AR032628A1
AR032628A1 ARP010103576A ARP010103576A AR032628A1 AR 032628 A1 AR032628 A1 AR 032628A1 AR P010103576 A ARP010103576 A AR P010103576A AR P010103576 A ARP010103576 A AR P010103576A AR 032628 A1 AR032628 A1 AR 032628A1
Authority
AR
Argentina
Prior art keywords
dihydro
oxo
piridilsulfonil
etilpiperazina
metoxyethyl
Prior art date
Application number
ARP010103576A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0018656A external-priority patent/GB0018656D0/en
Priority claimed from GB0106464A external-priority patent/GB0106464D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of AR032628A1 publication Critical patent/AR032628A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Un compuesto polimorfo de 1-{6-etoxi-5-[3-etil-6,7-dihidro-2-(2-metoxietil)-7-oxo-2H-pirazolo[4,3-d]pirimidin-5-il]-3-piridilsulfonil}-4-etilpiperazina de formula (1) que tiene un diagrama simulado de difraccion de rayos X del polvo con los picos principales sustancialmente como se definen a continuacion: donde dicho diagrama PXRD se genera usando rayos X K-alfa1 de cobre que tienen una longitud de onda de 1,54178 Angstroms. Este compuesto es un inhibidor selectivo y potente de la cGMP-PDE5 y especialmente util en el tratamiento, entre otros, de la disfuncion eréctil en los varones.
ARP010103576A 2000-07-28 2001-07-26 Compuesto polimorfo de 1-{6-etoxi-5-[3-etil-6,7-dihidro-2-(2-metoxietil)-7-oxo-2h-pirazolo[4,3-d]pirimidin-5-il]-3-piridilsulfonil}-4-etilpiperazina AR032628A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0018656A GB0018656D0 (en) 2000-07-28 2000-07-28 Pharmaceutically active compounds
GB0106464A GB0106464D0 (en) 2001-03-15 2001-03-15 Crystalline therapeutic agent

Publications (1)

Publication Number Publication Date
AR032628A1 true AR032628A1 (es) 2003-11-19

Family

ID=26244756

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010103576A AR032628A1 (es) 2000-07-28 2001-07-26 Compuesto polimorfo de 1-{6-etoxi-5-[3-etil-6,7-dihidro-2-(2-metoxietil)-7-oxo-2h-pirazolo[4,3-d]pirimidin-5-il]-3-piridilsulfonil}-4-etilpiperazina

Country Status (46)

Country Link
EP (1) EP1305314B1 (es)
JP (1) JP2004505087A (es)
KR (1) KR100457937B1 (es)
CN (1) CN1207297C (es)
AP (1) AP1400A (es)
AR (1) AR032628A1 (es)
AT (1) ATE286901T1 (es)
AU (2) AU7269001A (es)
BG (1) BG107266A (es)
BR (1) BR0112734A (es)
CA (1) CA2417264C (es)
CZ (1) CZ2003126A3 (es)
DE (1) DE60108398T2 (es)
DO (1) DOP2001000217A (es)
DZ (1) DZ3364A1 (es)
EA (1) EA004681B1 (es)
EC (1) ECSP034454A (es)
EE (1) EE200300045A (es)
ES (1) ES2231521T3 (es)
GE (1) GEP20053494B (es)
HK (1) HK1055954A1 (es)
HR (1) HRP20030061A2 (es)
HU (1) HUP0302982A3 (es)
IL (1) IL153226A0 (es)
IN (1) IN2002MU01649A (es)
IS (1) IS6626A (es)
MA (1) MA26931A1 (es)
MX (1) MX233602B (es)
MY (1) MY117831A (es)
NO (1) NO324220B1 (es)
NZ (1) NZ523226A (es)
OA (1) OA12337A (es)
PA (1) PA8523501A1 (es)
PE (1) PE20020277A1 (es)
PH (1) PH12001001922B1 (es)
PL (1) PL365133A1 (es)
PT (1) PT1305314E (es)
SK (1) SK572003A3 (es)
SV (1) SV2001000570A (es)
TN (1) TNSN01112A1 (es)
TW (1) TWI285643B (es)
UA (1) UA72631C2 (es)
UY (1) UY26854A1 (es)
WO (1) WO2002010171A1 (es)
YU (1) YU4703A (es)
ZA (1) ZA200301457B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004072079A1 (en) * 2003-02-11 2004-08-26 Pfizer Limited Hydrated and anhydrous sildenafil hemi-citrate compound
EP1620437B1 (en) 2003-04-29 2009-06-17 Pfizer Limited 5,7-diaminopyrazolo¬4,3-d pyrimidines useful in the traetment of hypertension
US7572799B2 (en) 2003-11-24 2009-08-11 Pfizer Inc Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
DK1742950T3 (da) 2004-04-07 2009-03-16 Pfizer Ltd Pyrazolo-[4,3-D]-pyrimidiner
EA012577B1 (ru) 2005-05-12 2009-10-30 Пфайзер Инк. БЕЗВОДНЫЕ КРИСТАЛЛИЧЕСКИЕ ФОРМЫ N-[1-(2-ЭТОКСИЭТИЛ)-5-(N-ЭТИЛ-N-МЕТИЛАМИНО)-7-(4-МЕТИЛПИРИДИН-2-ИЛАМИНО)-1Н-ПИРАЗОЛО[4,3-d]ПИРИМИДИН-3-КАРБОНИЛ]МЕТАНСУЛЬФОНАМИДА

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1073658E (pt) * 1998-04-20 2003-12-31 Pfizer Inibidores de ogmp pdes de pirazolopirimidinona para o tratamento da disfuncao sexual
TWI265925B (en) * 1999-10-11 2006-11-11 Pfizer Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them

Also Published As

Publication number Publication date
PA8523501A1 (es) 2002-10-24
AP2001002234A0 (en) 2001-09-30
DZ3364A1 (fr) 2002-02-07
TNSN01112A1 (fr) 2005-11-10
CN1444585A (zh) 2003-09-24
AP1400A (en) 2005-04-28
NZ523226A (en) 2003-07-25
IL153226A0 (en) 2003-07-06
WO2002010171A1 (en) 2002-02-07
MY117831A (en) 2004-08-30
MX233602B (es) 2006-01-10
UA72631C2 (uk) 2005-03-15
BG107266A (bg) 2003-07-31
MXPA03000856A (es) 2003-06-06
GEP20053494B (en) 2005-04-25
UY26854A1 (es) 2002-02-28
JP2004505087A (ja) 2004-02-19
SK572003A3 (en) 2004-05-04
TWI285643B (en) 2007-08-21
AU2001272690B2 (en) 2005-12-08
EP1305314B1 (en) 2005-01-12
EE200300045A (et) 2004-12-15
PE20020277A1 (es) 2002-05-11
DOP2001000217A (es) 2002-10-30
EA200300079A1 (ru) 2003-06-26
HRP20030061A2 (en) 2003-04-30
OA12337A (en) 2006-05-15
PT1305314E (pt) 2005-04-29
CA2417264A1 (en) 2002-02-07
CN1207297C (zh) 2005-06-22
CA2417264C (en) 2007-06-12
PH12001001922B1 (en) 2006-11-21
IN2002MU01649A (es) 2004-12-11
YU4703A (sh) 2006-01-16
BR0112734A (pt) 2004-08-10
ATE286901T1 (de) 2005-01-15
EA004681B1 (ru) 2004-06-24
NO20030416D0 (no) 2003-01-27
DE60108398D1 (de) 2005-02-17
CZ2003126A3 (cs) 2004-02-18
IS6626A (is) 2002-11-18
NO324220B1 (no) 2007-09-10
AU7269001A (en) 2002-02-13
HUP0302982A2 (hu) 2003-12-29
NO20030416L (no) 2003-02-05
ZA200301457B (en) 2004-04-28
HK1055954A1 (en) 2004-01-30
EP1305314A1 (en) 2003-05-02
HUP0302982A3 (en) 2005-01-28
MA26931A1 (fr) 2004-12-20
ES2231521T3 (es) 2005-05-16
KR100457937B1 (ko) 2004-11-20
ECSP034454A (es) 2003-03-10
SV2001000570A (es) 2002-09-03
DE60108398T2 (de) 2005-12-22
KR20030016430A (ko) 2003-02-26
PL365133A1 (en) 2004-12-27

Similar Documents

Publication Publication Date Title
ECSP055840A (es) Derivados de 4 -tetrazolil-4fenilpiperidina para el tratamiento del dolor
DE60319406D1 (de) Meso-substituierte porphyrine
EA200201179A1 (ru) Производные 2-аминокарбонил-9h-пурина
AR027065A1 (es) Composiciones farmaceuticas que proporcionan concentraciones potenciadas de farmaco
ES2195785B1 (es) Nuevos derivados de piridazin-3(2h)-ona.
UY27943A1 (es) Composiciones y mctodos para tratar el crncer usando inmunoconjugados de anticuerpo para cd44 citotnxicos y agentes quimioterapcuticos
CY1114359T1 (el) Παραγοντας κατα ογκων περιλαμβανων τον αναστολεα αποακετυλασης ιστονης fk228 kai ton αναστολεα τοποϊσομερασης ιι δοξορουβικινη
UY27760A1 (es) Nuevos derivados de pirrolidinio.
AR030245A1 (es) Composiciones de gel que contienen metronidazol
PA8556201A1 (es) Alquinos como inhibidores de metaloproteinasa de matriz
CY1109219T1 (el) Ινδολο, αζαινδολο και σχετικα ετεροκυκλικα αμιδοπιπεραζινο παραγωγα
GB0121023D0 (en) Compound
AR022593A1 (es) Un metodo para efectuar el blanqueado realzado de los dientes
PA8582101A1 (es) Indoles sustituidos en posicion 2,4
AR086573A2 (es) Derivados de 5-(piridin-3-il)-1-azabiciclo[3,2,1]octano y octeno, su preparacion y su aplicacion en terapeutica
AR018162A1 (es) Pirroles substituidos, composicion farmaceutica y el uso de los mismos para la preparacion de dicha composicion farmaceutica
AR032628A1 (es) Compuesto polimorfo de 1-{6-etoxi-5-[3-etil-6,7-dihidro-2-(2-metoxietil)-7-oxo-2h-pirazolo[4,3-d]pirimidin-5-il]-3-piridilsulfonil}-4-etilpiperazina
AR041713A1 (es) Una composicoin farmaceutica de duracion prolongada
AR004474A1 (es) Compuestos de 10-aminoalifatil-dibenz [b,f]oxepinas antineurodegenerativamente activas, utiles para el tratamiento de estados neurodegenerativos y composiciones farmaceuticas que los contienen
UY26648A1 (es) Inhibidores de vasopeptidasa para tratar hipertensión sistólica aislada
BR0110902A (pt) Inibidores de mmp-9/mmp-2
CO5560584A2 (es) Nueva combinacion
ATE180485T1 (de) Nitrone verwendbar zum abfangen von freien radikalen
TR200001655T2 (tr) Ekinokandin türevleri, hazırlama yöntemi ve anti-fungal maddeler
PA8593701A1 (es) [4-(3-aminometilfenil)piperidin-1-il]-[5-(2-fluorofenil-etinil)furan-2-il]-metanoma como inhibidor de triptasa de mastocitos

Legal Events

Date Code Title Description
FB Suspension of granting procedure